Quest Diagnostics Incorporated (DGX) Q3 2021 Earnings Results

Quest Diagnostics Beats on EPS, Stock Down 1.0%

Quest Diagnostics reported a strong earnings per share figure that exceeded expectations, indicating solid performance in that area. However, the stock reacted negatively, declining by 1.0%. This could suggest that investors were looking for additional information or guidance that was not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.96	N/A	+33.96%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Quest Diagnostics Beats on EPS, Stock Down 1.0%

Key numbers

Management commentary

Quest Diagnostics Incorporated

More earnings this week

Quest Diagnostics Beats on EPS, Stock Down 1.0%

Key numbers

Management commentary